Story perspectives

Revvity Beats EPS Estimates but Lowers Guidance Amid Challenges

7/29/2025

49 4

Summary

Story summary

Revvity, Inc. reported Q2 2025 adjusted EPS of $1.18, exceeding estimates but down 3.3% year-over-year.
Revenue reached $720 million, a 4% increase from last year, surpassing expectations.
The company lowered its EPS guidance to $4.85-$4.95 due to reduced demand in China and margin pressures.
Revvity's diagnostics segment saw a double-digit decline in China from new insurance reimbursement policies.
Despite challenges, Revvity raised its 2025 revenue forecast to $2.84-$2.88 billion, indicating confidence in growth.

History

Historical Context

The U.S.-China trade war intensified in 2018, resulting in a 0.5% decline in global GDP growth due to increased tariffs. This conflict has significantly impacted multinational companies like Revvity, Inc., which now faces reduced demand in China. As Revvity adjusts its earnings guidance, these economic pressures underscore the need for strategic adaptations in a rapidly changing market landscape.

1 of 2

Story summary

Revvity, Inc. reported Q2 2025 adjusted EPS of $1.18, exceeding estimates but down 3.3% year-over-year.
Revenue reached $720 million, a 4% increase from last year, surpassing expectations.
The company lowered its EPS guidance to $4.85-$4.95 due to reduced demand in China and margin pressures.
Revvity's diagnostics segment saw a double-digit decline in China from new insurance reimbursement policies.
Despite challenges, Revvity raised its 2025 revenue forecast to $2.84-$2.88 billion, indicating confidence in growth.

1 / 2